Growth Metrics

DBV Technologies (DBVT) Cash from Operations (2014 - 2026)

DBV Technologies (DBVT) reported Cash from Operations of 49100000.0 for Q1 2026, down 149.24% year-over-year from 99718556.7 in Q1 2025, and down 39.6% on a QoQ basis from 35173000.0 in Q4 2025.

DBV Technologies (DBVT) has 13 years of Cash from Operations data on file, last reported at 49100000.0 in Q1 2026.

  • Quarterly Cash from Operations fell 149.24% year-over-year to 49100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 150581000.0 (down 68.28% YoY) and the FY2025 annual result came in at 121181000.0, down 15.99% from the prior year.
  • Cash from Operations eased to 49100000.0 in Q1 2026 per DBVT's latest filing, from 35173000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1483000.0 in Q1 2022 and bottomed at 49100000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 22457000.0 (2024), against an average of 24122000.0.
  • The widest annual swing landed in 2022, when Cash from Operations surged 95.9%; it then plunged 1305.33% in 2023.
  • Tracing DBVT's Cash from Operations over 5 years: stood at 23885000.0 in 2022, then surged by 42.7% to 13686000.0 in 2023, then gained by 10.48% to 12252000.0 in 2024, then tumbled by 187.08% to 35173000.0 in 2025, then slumped by 39.6% to 49100000.0 in 2026.
  • Per Business Quant, the three latest DBVT Cash from Operations figures stand at 49100000.0 (Q1 2026), 35173000.0 (Q4 2025), and 32435000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.43 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.08 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 70.50 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -49.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -49.10 Mn
Mar 31, 2026 -49.10 Mn
Dec 31, 2025 -35.17 Mn
Dec 31, 2025 -35.17 Mn
Sep 30, 2025 -32.44 Mn
Sep 30, 2025 -32.44 Mn
Jun 30, 2025 -33.87 Mn
Jun 30, 2025 -33.87 Mn
Mar 31, 2025 -19.70 Mn
Mar 31, 2025 -19.70 Mn
Dec 31, 2024 -12.25 Mn
Dec 31, 2024 -12.25 Mn
Sep 30, 2024 -22.46 Mn
Sep 30, 2024 -22.46 Mn
Jun 30, 2024 -35.07 Mn
Jun 30, 2024 -35.07 Mn
Mar 31, 2024 -34.69 Mn
Mar 31, 2024 -34.69 Mn
Dec 31, 2023 -13.69 Mn
Dec 31, 2023 -13.69 Mn
Sep 30, 2023 -19.57 Mn
Sep 30, 2023 -19.57 Mn
Jun 30, 2023 -25.55 Mn
Jun 30, 2023 -25.55 Mn
Mar 31, 2023 -20.84 Mn
Mar 31, 2023 -20.84 Mn
Dec 31, 2022 -23.89 Mn
Dec 31, 2022 -23.89 Mn
Sep 30, 2022 -20.05 Mn
Sep 30, 2022 -20.05 Mn
Jun 30, 2022 -10.25 Mn
Jun 30, 2022 -10.25 Mn
Mar 31, 2022 -1.48 Mn
Mar 31, 2022 -1.48 Mn
Dec 31, 2021 -18.79 Mn
Dec 31, 2021 -18.79 Mn
Sep 30, 2021 -22.95 Mn
Sep 30, 2021 -22.95 Mn
Jun 30, 2021 -30.30 Mn
Jun 30, 2021 -30.30 Mn
Mar 31, 2021 -36.20 Mn
Mar 31, 2021 -36.20 Mn
Dec 31, 2020 -33.53 Mn
Dec 31, 2020 -33.53 Mn
Sep 30, 2020 -42.23 Mn
Sep 30, 2020 -42.23 Mn
Jun 30, 2020 -40.17 Mn
Jun 30, 2020 -40.17 Mn
Mar 31, 2020 -49.68 Mn
Mar 31, 2020 -49.68 Mn
Dec 31, 2019 63.00 Mn
Dec 31, 2019 63.00 Mn
Sep 30, 2019 -120.47 Mn
Sep 30, 2019 -120.47 Mn
Jun 30, 2019 -86.71 Mn
Jun 30, 2019 -86.71 Mn
Dec 31, 2018 -155.94 Mn
Dec 31, 2018 -155.94 Mn
Sep 30, 2018 -123.40 Mn
Sep 30, 2018 -123.40 Mn
Jun 30, 2018 -77.78 Mn
Jun 30, 2018 -77.78 Mn
Dec 31, 2017 -134.60 Mn
Dec 31, 2017 -134.60 Mn
Dec 31, 2016 -64.28 Mn
Dec 31, 2016 -64.28 Mn
Dec 31, 2015 -13.64 Mn
Dec 31, 2015 -13.64 Mn
Dec 31, 2014 -13.09 Mn
Dec 31, 2014 -13.09 Mn